Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.
Delta Sleep-Inducing Peptide, a nonapeptide marketed for sleep, withdrawal and recovery. Not a clean first candidate for any established use.
Sleep is a strong male-health need, driving interest despite weak data.
| Claim | Strongest evidence |
|---|---|
| Sleep / insomnia | R Regulatory only |
| Recovery / withdrawal | D Cell / mechanistic |
FDA noted gaps in safety/effectiveness and the availability of approved therapies for the evaluated conditions; staff proposed not adding it.
Weak human data. Approved sleep therapies already exist and are better characterized.
No. FDA noted safety/effectiveness gaps and proposed not adding it.
Choose your main interest, then get one email when regulatory status changes or strong new evidence lands. Health topics only. Unsubscribe anytime.
Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.